Barrington Research reaffirmed their outperform rating on shares of U.S. Physical Therapy (NYSE:USPH – Free Report) in a research report report published on Friday,Benzinga reports. The firm currently has a $103.00 price objective on the stock.
A number of other research firms also recently weighed in on USPH. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. JPMorgan Chase & Co. decreased their target price on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Monday, November 24th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. Four equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average price target of $105.33.
Check Out Our Latest Report on USPH
U.S. Physical Therapy Trading Down 1.6%
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Hantz Financial Services Inc. raised its holdings in U.S. Physical Therapy by 56.4% in the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after acquiring an additional 132 shares during the period. Cullen Frost Bankers Inc. grew its position in shares of U.S. Physical Therapy by 171.8% in the second quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock valued at $35,000 after purchasing an additional 280 shares during the last quarter. Advisory Services Network LLC bought a new position in shares of U.S. Physical Therapy during the third quarter worth approximately $39,000. EverSource Wealth Advisors LLC increased its stake in shares of U.S. Physical Therapy by 68.8% during the third quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock worth $40,000 after purchasing an additional 192 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in U.S. Physical Therapy by 207.1% during the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock worth $40,000 after purchasing an additional 348 shares during the last quarter.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
See Also
- Five stocks we like better than U.S. Physical Therapy
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
